col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


42 Ergebisse       Seite 1

 [1] 
Elsevier: Parkinsonism & Related Disorders
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jan―05 Increasing Parkinson's disease related mortality through the pandemic and beyond: An update Ugo Fedeli, Giacomo Danieli, Claudio Barbiellini Amidei, Veronica Casotto
2 [GO] 2023―Aug―22 A case of levodopa responsive parkinsonism due to methanol toxicity, an impact of COVID-19 crisis M. Shah, L. Patil, M. Bhatt
3 [GO] 2023―Aug―22 Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine J. Sławek, F. Przytuła, J. Kasprzak, J. Dulski
4 [GO] 2023―Aug―22 Model of virtual communication of the Reference center for invasive methods of treatment of Parkinson's disease during the COVID-19 pandemic V. Komen, E. Papic, G. Rozmaric, V. Vuletic
5 [GO] 2023―Aug―22 Impact of telemedicine among Parkinson’s disease patients during COVID-19 pandemic in Nepal R. Ojha, R. Karn, B.P. Gajurel, R. Rajbhandari, N. Gautam, A. Shrestha, et al. (+3)
6 [GO] 2023―Aug―22 Impact of COVID-19 pandemic on eating behavior and body mass index in patients with Parkinson's disease of Northeastern México C.K. Lopez-Botello, S.A. Castillo-Torres, I. Estrada-Bellmann, B.E. Chávez-Luévanos
7 [GO] 2023―Aug―22 A Croatian tertiary center experience on the impact of the COVID-19 pandemic on Parkinson's disease: a cross-sectional telephone study M. Hero, G. Rožmarić, V. Rački, V. Vuletić
8 [GO] 2023―Aug―22 Clinical evaluation of neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic: risk factors M. Salokhiddinov, R. Nuriddinov
9 [GO] 2023―Aug―22 Leucine-rich repeat kinase2 (LRRK2) associated Parkinson's disease: less vulnerable during Covid-19 pandemic? A. Gharbi, I. Kacem, I. Sghaier, S. Mrabet, A. Souissi, A. Gargouri, et al. (+2)
10 [GO] 2023―Aug―22 Violation of motor and non-motor functions in patients with COVID-19 with oral pathology M. Giyazova, M. Sanoeva
11 [GO] 2023―Aug―22 Cavernous sinus thrombosis in patients after coronavirus disease patients with vascular parkinsonism in Uzbekistan D. Bobamuratova, S. Boymuradov, T. Bobomuratov, D. Akramova
12 [GO] 2023―Aug―22 Amantadine treatment in Parkinson’s disease patients as a modulatory factor of SARS-Cov-2 infection S. Szlufik, A. Chudzik, A. Przybyszewski, D. Koziorowski
13 [GO] 2023―Aug―22 Optimization of recruitment for movement disorders clinical trials in a pandemic: a single center experience O. Phillips, J. Kosco, M. Serrano, H. Fernandez
14 [GO] 2023―Apr―30 Frequency of Parkinson disease following COVID-19 infection: A two-year retrospective cohort study Alexander S. Wang, Jaime A. Perez, Steven A. Gunzler
15 [GO] 2022―Dez―06 Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicenter, retrospective, observational study Filip Przytuła, Jakub Kasprzak, Jarosław Dulski, Dariusz Koziorowski, Magdalena Kwaśniak-Butowska, Witold Sołtan, et al. (+4)
16 [GO] 2022―Apr―26 Parkinson’s disease related mortality: Long-term trends and impact of COVID-19 pandemic waves Ugo Fedeli, Veronica Casotto, Claudio Barbiellini Amidei, Mario Saia, Silvia Netti Tiozzo, Cristina Basso, Elena Schievano
17 [GO] 2022―Apr―22 Success of home-to-home tele-neuropsychology (TeleNP) in deep brain stimulation (DBS) candidacy assessments: COVID-19 and beyond Marina Sarno, Annelly Buré-Reyes, Scott Harcourt, Ihtsham Haq, Corneliu Luca, Jonathan Jagid, Bonnie Levin
18 [GO] 2021―Nov―11 The impact of lockdown on Functional Motor Disorders patients during the first COVID-19 outbreak: A case-control study Ilaria A. Di Vico, Marianna Riello, Angela Marotta, Michela Colombari, Angela Sandri, Michele Tinazzi, Maria Elisabetta Zanolin
19 [GO] 2021―Okt―19 North American survey on impact of the COVID-19 pandemic shutdown on DBS care Mustafa S. Siddiqui, Joohi Jimenez-Shahed, Zoltan Mari, Benjamin L. Walter, Sol De Jesus, Fedor Panov, et al. (+8)
20 [GO] 2021―Sep―01 Clinical perception and management of Parkinson’s disease during the COVID-19 pandemic: a Canadian experience Aurelie de Rus Jacquet, Sarah Bogard, Catherine P. Normandeau, Clotilde Degroot, Ronald B. Postuma, Nicolas Dupré, et al. (+5)
21 [GO] 2021―Jul―13 A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study Margherita Fabbri, Clémence Leung, Guillaume Baille, Matthieu Béreau, Christine Brefel Courbon, Giovanni Castelnovo, et al. (+14)
22 [GO] 2021―Jul―08 Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran Mehri Salari, Masoud Etemadifar, Farzad Ashrafi, Davood Ommi, Zahra Aminzade, Sepand Tehrani Fateh
23 [GO] 2021―Mai―14 The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations M.K. York, E. Farace, L. Pollak, D. Floden, G. Lin, K. Wyman-Chick, et al. (+6)
24 [GO] 2021―Apr―25 Parkinsonism Hyperpyraexia Syndrome in Parkinson’s Disease Patients Undergoing Deep Brain Stimulation: An Indirect Consequence of COVID-19 Lockdowns Onanong Phokaewvarangkul, Sasivimol Virameteekul, Roongroj Bhidayasiri
25 [GO] 2021―Apr―24 Parkinson’s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A Systematic Review, Meta-Analysis, and Meta-Regression Cynthia Putri, Timotius Ivan Hariyanto, Joshua Edward Hananto, Kevin Christian, Rocksy Fransisca V. Situmeang, Andree Kurniawan
26 [GO] 2021―Apr―13 Uptake of telehealth in Parkinson’s disease clinical care and research during COVID-19 pandemic Vikram Shivkumar, Thyagarajan Subramanian, Pinky Agarwal, Zoltan Mari, Tiago Mestre
27 [GO] 2021―Mrz―30 Effects of COVID -19 pandemic and lockdown on people with multiple system atrophy participating in a therapeutic education program Ana Cámara, Yaroslau Compta, Alexandra Pérez-Soriano, Núria Montagut, Laura Maragall, Emma Ludeña, et al. (+20)
28 [GO] 2021―Mrz―28 People with Parkinson’s report increased impulse control behaviours during the COVID-19 UK lockdown Elizabeth Yule, Jennifer McBride, Ellen Poliakoff, Jade S. Pickering
29 [GO] 2021―Mrz―19 Analysis of Nationwide Multimodal Complex Treatment and Drug Pump Therapy in Parkinson´s Disease in Times of COVID-19 Pandemic in Germany Daniel Richter, Raphael Scherbaum, Dirk Bartig, Ralf Gold, Christos Krogias, Lars Tönges
30 [GO] 2020―Nov―19 Editorial: Neuropalliative care for movement disorders in the time of COVID-19 Janis M. Miyasaki, Maisha T. Robinson
31 [GO] 2020―Okt―06 Hoping for the best, planning for the worst: Palliative care approach to Parkinson disease during the COVID-19 pandemic Indu Subramanian
32 [GO] 2020―Sep―23 The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic Joomee Song, Jong Hyeon Ahn, Inyoung Choi, Jun Kyu Mun, Jin Whan Cho, Jinyoung Youn
33 [GO] 2020―Sep―06 COVID-19 in Parkinson's disease: Report on prevalence and outcome Carlo Alberto Artusi, Alberto Romagnolo, Gabriele Imbalzano, Alberto Marchet, Maurizio Zibetti, Mario Giorgio Rizzone, Leonardo Lopiano
34 [GO] 2020―Sep―06 Impact of home confinement during COVID-19 pandemic on Parkinson's disease Niraj Kumar, Ravi Gupta, Hrishikesh Kumar, Sahil Mehta, Roopa Rajan, Deva Kumar, et al. (+11)
35 [GO] 2020―Aug―13 Predictors of COVID-19 outcome in Parkinson's disease Alfonso Fasano, Antonio E. Elia, Carlo Dallocchio, Margherita Canesi, Dario Alimonti, Chiara Sorbera, et al. (+2)
36 [GO] 2020―Jul―22 The psychological impact of COVID-19 among a sample of Italian patients with functional neurological disorders: A preliminary study Veronica Nisticò, Diana Goeta, Orsola Gambini, Benedetta Demartini
37 [GO] 2020―Jun―18 May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2? F. Spina Tensini, T. Spina Tensini, G.L. Franklin, H.A.G. Teive
38 [GO] 2020―Jun―15 Medical education in movement disorders during the COVID-19 pandemic José Rafael P. Zuzuárregui, Ian O. Bledsoe, Ethan G. Brown, Cameron G. Dietiker, Nicholas B. Galifianakis
39 [GO] 2020―Jun―10 Telemedicine for parkinsonism: A two-step model based on the COVID-19 experience in Milan, Italy Roberto Cilia, Francesca Mancini, Bastiaan R. Bloem, Roberto Eleopra
40 [GO] 2020―Jun―04 E-Rehabilitation: One solution for patients with Parkinson's disease in COVID-19 era Adarsh Kumar Srivastav, Asir John Samuel
41 [GO] 2020―Jun―04 Adaptive neurology in COVID-19 times Elena Moro, Hubert H. Fernandez
42 [GO] 2020―Mai―08 Rapid worsening in Parkinson's disease may hide COVID-19 infection Elodie Hainque, David Grabli
 [1] 

42 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec